AUPH Overview
Upcoming Projects (AUPH)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AUPH)
-
A Second Opinion: Looking at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Tickers: KZR, GSK, AUPH
Executed On: Sep 01, 2022 at 01:00 PM EDT -
A look at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Tickers: KZR, AUPH
Executed On: Jun 30, 2022 at 02:00 PM EDT
Upcoming & Overdue Catalysts (AUPH)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AUPH)
-
Aurinia (AUPH) Prices Equity Offering of 22.3M Shares of Common Stock at $6.75
Ticker: AUPH
Occurred on: Mar 15, 2017 -
Aurinia (AUPH) Enters Underwriting Agreement for ~$25MM of Common Stock and Warrants
Ticker: AUPH
Occurred on: Dec 22, 2016 -
Voclosporin Achieves Primary and All Pre-specified Secondary Endpoints in its Phase IIb AURA-LV Study for Lupus Nephritis (LN)
Ticker: AUPH
Occurred on: Sep 29, 2016 -
Aurinia (AUPH) Expects Data Readout in 2016 of Phase 2b AURA-LV Study of Voclosporin in Active Lupus Nephritis
Ticker: AUPH
Occurred on: Aug 15, 2016 -
Phase 2b data of Voclosporin for lupus nephritis possible 2H 2016 (BPC estimate only)
Ticker: AUPH
Occurred on: Aug 15, 2016 -
Aurinia Announces 24 Week Remission Rates From the First Seven Patients In Its Open Label Aurion Study In Lupus Nephritis
Ticker: AUPH
Occurred on: Jun 28, 2016 -
Aurina Receives FDA Fast Track Designation for Voclosporin for the Treatment of Lupus Nephritis
Ticker: AUPH
Occurred on: Mar 02, 2016 -
Aurinia Announces Preliminary Topline Data From its Open Label Aurion Study in Lupus Nephritis
Ticker: AUPH
Occurred on: Feb 08, 2016
Strategic Initiatives (AUPH)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
